BAYER AG |
Market Closed -
Other stock markets
|
After market 03:59:59 pm | |||
| 29.32 EUR | +0.36% |
|
29.28 | -0.14% |
| 01:57pm | BAYER AG : Barclays remains Neutral | ZD |
| 10:06am | Chemical industry sees first rays of hope and becomes more confident for 2024 | DP |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
29.22
EUR
Average target price
36.9
EUR
Spread / Average Target
+26.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.80% | 31.05B | |
| +31.37% | 588B | |
| -2.60% | 364B | |
| +20.83% | 326B | |
| +5.69% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +10.77% | 167B | |
| +0.10% | 161B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer Appoints Former Roche Executive as CEO
